The role of aggressive regional therapy for colorectal liver metastases.

about

Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer Fluoropyrimidine-HAI (hepatic arterial infusion) versus systemic chemotherapy (SCT) for unresectable liver metastases from colorectal cancer

P2860

Q24240109-8B325A5A-4291-423E-BBF6-0BB939DCC3FD Q24240763-611E3249-4F21-4C07-801A-8B6E5CA15657

P2860

The role of aggressive regional therapy for colorectal liver metastases.

Item

http://www.wikidata.org/entity/Q36946762

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

The role of aggressive regional therapy for colorectal liver metastases.

@en

type

Item

label

The role of aggressive regional therapy for colorectal liver metastases.

@en

prefLabel

The role of aggressive regional therapy for colorectal liver metastases.

@en

P1476

The role of aggressive regional therapy for colorectal liver metastases

@en

P2093

Rebekah R White

http://www.w3.org/2001/XMLSchema#string

P2860

Phase II trial of cetuximab in patients with refractory colorectal cancer that expresses the epidermal growth factor receptor.

Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

Cancer statistics, 2006

A two-stage hepatectomy procedure combined with portal vein embolization to achieve curative resection for initially unresectable multiple and bilobar colorectal liver metastases.

Phase I and pharmacokinetic study of hepatic arterial infusion with oxaliplatin in combination with folinic acid and 5-fluorouracil in patients with hepatic metastases from colorectal cancer.

Hepatic arterial infusion of floxuridine and dexamethasone plus high-dose Mitomycin C for patients with unresectable hepatic metastases from colorectal carcinoma.

Clinical score for predicting recurrence after hepatic resection for metastatic colorectal cancer: analysis of 1001 consecutive cases.

Hepatic arterial infusion of chemotherapy after resection of hepatic metastases from colorectal cancer.

Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group.

P304

458-463

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/07357900701508561

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

William R Jarnagin

P577

2007-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17882658

http://www.w3.org/2001/XMLSchema#string

The role of aggressive regional therapy for colorectal liver metastases.

about

P2860

P2860

The role of aggressive regional therapy for colorectal liver metastases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698